190 related articles for article (PubMed ID: 24030822)
41. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel.
Lummis SC; Beene DL; Lee LW; Lester HA; Broadhurst RW; Dougherty DA
Nature; 2005 Nov; 438(7065):248-52. PubMed ID: 16281040
[TBL] [Abstract][Full Text] [Related]
42. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
[TBL] [Abstract][Full Text] [Related]
43. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.
Bouzat C; Gumilar F; Spitzmaul G; Wang HL; Rayes D; Hansen SB; Taylor P; Sine SM
Nature; 2004 Aug; 430(7002):896-900. PubMed ID: 15318223
[TBL] [Abstract][Full Text] [Related]
44. Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors.
Das P; Dillon GH
J Pharmacol Exp Ther; 2005 Jul; 314(1):320-8. PubMed ID: 15814570
[TBL] [Abstract][Full Text] [Related]
45. Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT
Basak S; Gicheru Y; Rao S; Sansom MSP; Chakrapani S
Nature; 2018 Nov; 563(7730):270-274. PubMed ID: 30401837
[TBL] [Abstract][Full Text] [Related]
46. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
Lochner M; Lummis SC
Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
[TBL] [Abstract][Full Text] [Related]
47. Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3 receptor.
Sullivan NL; Thompson AJ; Price KL; Lummis SC
Mol Membr Biol; 2006; 23(5):442-51. PubMed ID: 17060161
[TBL] [Abstract][Full Text] [Related]
48. Triple arginines as molecular determinants for pentameric assembly of the intracellular domain of 5-HT
Pandhare A; Pirayesh E; Stuebler AG; Jansen M
J Gen Physiol; 2019 Sep; 151(9):1135-1145. PubMed ID: 31409663
[TBL] [Abstract][Full Text] [Related]
49. Assembly of nicotinic and other Cys-loop receptors.
Tsetlin V; Kuzmin D; Kasheverov I
J Neurochem; 2011 Mar; 116(5):734-41. PubMed ID: 21214570
[TBL] [Abstract][Full Text] [Related]
50. Unraveling mechanisms underlying partial agonism in 5-HT3A receptors.
Corradi J; Bouzat C
J Neurosci; 2014 Dec; 34(50):16865-76. PubMed ID: 25505338
[TBL] [Abstract][Full Text] [Related]
51. Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression.
Krzywkowski K; Jensen AA; Connolly CN; Bräuner-Osborne H
Pharmacogenet Genomics; 2007 Apr; 17(4):255-66. PubMed ID: 17496724
[TBL] [Abstract][Full Text] [Related]
52. Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes.
Na JH; Shin J; Jung Y; Lim D; Shin YK; Yu YG
Protein Expr Purif; 2013 Apr; 88(2):190-5. PubMed ID: 23321066
[TBL] [Abstract][Full Text] [Related]
53. The 5-HT3 receptor as a therapeutic target.
Thompson AJ; Lummis SC
Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
[TBL] [Abstract][Full Text] [Related]
54. Interactions of granisetron with an agonist-free 5-HT3A receptor model.
Joshi PR; Suryanarayanan A; Hazai E; Schulte MK; Maksay G; Bikádi Z
Biochemistry; 2006 Jan; 45(4):1099-105. PubMed ID: 16430206
[TBL] [Abstract][Full Text] [Related]
55. RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.
Walstab J; Hammer C; Lasitschka F; Möller D; Connolly CN; Rappold G; Brüss M; Bönisch H; Niesler B
J Biol Chem; 2010 Aug; 285(35):26956-26965. PubMed ID: 20522555
[TBL] [Abstract][Full Text] [Related]
56. Delineating the Site of Interaction of the 5-HT
Pirayesh E; Stuebler AG; Pandhare A; Jansen M
Biophys J; 2020 Feb; 118(4):934-943. PubMed ID: 31870537
[TBL] [Abstract][Full Text] [Related]
57. Binding motif for RIC-3 chaperon protein in serotonin type 3A receptors.
Do HQ; Jansen M
J Gen Physiol; 2023 Jun; 155(6):. PubMed ID: 37026993
[TBL] [Abstract][Full Text] [Related]
58. Immunological characterization of 5-HT3 receptor transmembrane topology.
Spier AD; Lummis SC
J Mol Neurosci; 2002 Jun; 18(3):169-78. PubMed ID: 12059035
[TBL] [Abstract][Full Text] [Related]
59. Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors.
Rayes D; De Rosa MJ; Sine SM; Bouzat C
J Neurosci; 2009 May; 29(18):6022-32. PubMed ID: 19420269
[TBL] [Abstract][Full Text] [Related]
60. A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function.
Wu DF; Othman NA; Sharp D; Mahendra A; Deeb TZ; Hales TG
J Physiol; 2010 Feb; 588(Pt 4):603-16. PubMed ID: 19933756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
